GSK-690693 T6285
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.
CAS nr:
937174-76-0
Purity:
98%
Molecular Weight:
425,48
SMILES:
CCn1c(nc2c1c(OC[C@H]1CCCNC1)cnc2C#CC(C)(C)O)c1nonc1N
Formula:
C21H27N7O3
Pathway:
Cytoskeletal Signaling,Chromatin/Epigenetic,PI3K/Akt/mTOR signaling,Autophagy,Cytoskeletal Signaling,PI3K/Akt/mTOR signaling,Proteases/Proteasome
Target:
PKC,PKC,AMPK,Autophagy,Akt,Akt,Serine Protease
